International journal of molecular sciences , 24 (13), 10449
The main focus is on the two most common neurodegenerative diseases, Alzheimers disease and Parkinsons disease, other neurodegenerative diseases are also involved in a small amount
A few patients have reported heart attacks while using Tradjenta, but this is extremely rare: according to clinical trials published in 2012 by Lilly Research Laboratories (the company that makes Tradjenta), only 3 out of every 10,000 patients had heart attacks while taking this drug
This study reveals a new mechanism through which FAO metabolism participates in joint destruction in RA and provides a novel therapeutic direction for the development of drugs against bone destruction in patients with RA
Its natural to have questions and concerns, and thats why open communication with your doctor is so important